CHU de Nantes - Hôpital Laennec

At CHU de Nantes - Hôpital Laennec, clinical research is centered on neurology with a strong focus on Parkinson’s disease and progressive multiple sclerosis. The studies are designed to assess new treatment options, compare them with placebo, and better understand how these conditions affect patients over time.

• Research on early Parkinson’s disease is exploring whether new therapies can improve symptoms and slow worsening.
• Trials in Parkinson’s disease are evaluating safety, tolerability, and treatment effectiveness for adults living with the condition.
• Work in progressive multiple sclerosis is focused on long-term effectiveness and safety of treatment in French patients.

This research environment reflects a practical effort to improve both symptom control and long-term care in neurological disorders, with attention to patient safety and real-world benefit.